Death Row Inmates Sue the FDA Over Execution Drugs

Fight disinformation: Sign up for the free Mother Jones Daily newsletter and follow the news that matters.


“In keeping with established practice, FDA does not review or approve products for the purpose of lethal injection. FDA has not reviewed the products in this shipment to determine their identity, safety, effectiveness, purity, or any other characteristics.”

This is the statement now imprinted on shipments of lethal injection drugs that are brought into the country from foreign sources. Now, a group of six death row inmates is suing the Food and Drug Administration, claiming that the agency’s decision to allow one execution drug across U.S. borders without FDA approval is ”manifestly contrary to law and amount[s] to an abdication of the obligations imposed” by the Food, Drug and Cosmetic Act of 1938.

The prisoner’s lawsuit stand to throw a serious monkey wrench into the machinery of death. Sodium thiopental, an anesthetic, is one component of the three-drug death cocktail used by most death penalty states–and it is now seriously hard to come by in the United States. This fact has already delayed executions or changed execution protocols in several states.

Hospira, the only company approved to make sodium thiopental for use in the United States, suspended manufacture in 2009 because of a shortage of raw materials, and supplies were already running low in 2010. Last fall, Hospira announced that it would be making the drug only at its plant in Liscate, Italy. But Italy, like most of Europe, eschews capital punishment. As the AP reported in December, “Italy’s Radical Party brought a motion to Parliament, which passed overwhelmingly…, requiring Hospira to ensure that the drug would be used only for medical purposes and would not find its way into prisons.” In January, Hospira announced that it would simply stop importing sodium thiopental to the United States.

In the face of shortages, several states were already casting around for other sources. They included California, which just christened a new $900 million execution chamber at San Quentin in the hopes of overcoming a court-imposed ban on executions. According to KALW’s blog The Informant, documents obtained by the ACLU of Northern California “shed light on California’s frenzied scramble for lethal injection drugs,” in “a search that would eventually take them through Texas, Arizona, England, and Pakistan.”

Along with several other states, including Arizona and Tennessee, California ended up ordering sodium thiopental made in Britain, through a West London pharmaceutical supplier that doubles as a driving school, according to the BBC. That supply was soon cut off as well under a British government ban, but not before states received their first shipments of the drug, with the tacit cooperation of the FDA.

It’s these shipments that are at issue in the lawsuit filed last week against the FDA by the high-powered D.C. law firm of Sidley Austin. According to The Informant, ”many death penalty watchers have raised questions about the quality and legality of those drugs–saying that if the drug malfunctions, inmates could experience tremendous pain while dying, which they say violates the Eight Amendment’s ban on cruel and unusual punishment.” It is the FDA’s job to make sure that drugs imported to the United States are safe and effective, the lawsuit claims, and their actions with regard to the execution drug is illegal. (The full text of the suit, filed in U.S. District Court for Washington, D.C. on behalf of six inmates from Arizona, California, and Tennessee, can be found here.) The plaintiffs in the civil suit are seeking a declaratory judgement. If they succeed–or even if their case simply takes its time making its way through the courts–they could delay executions in several states.

That’s unlikely to happen, however, in Oklahoma and Ohio, which have begun using a substitute drug–pentobarbital, the drug commonly used to euthanize animals. In December, Oklahoma became the first state to execute a prisoner using pentobarbital, in place of sodium thiopental as part of a three-drug cocktail. In January, Ohio announced that it, too, would use pentobarbital–but alone, and in one massive dose. According to the Cincinnati Enquirer, “Ohio is on pace…to set a modern-day state record for executing the most condemned killers in one year.” On Tuesday, the Ohio Supreme Court set execution dates for nine condemned prisoners–approximately one a month through October–and may yet add more. These men will, quite literally, die like dogs.

WE'LL BE BLUNT

It is astonishingly hard keeping a newsroom afloat these days, and we need to raise $253,000 in online donations quickly, by October 7.

The short of it: Last year, we had to cut $1 million from our budget so we could have any chance of breaking even by the time our fiscal year ended in June. And despite a huge rally from so many of you leading up to the deadline, we still came up a bit short on the whole. We can’t let that happen again. We have no wiggle room to begin with, and now we have a hole to dig out of.

Readers also told us to just give it to you straight when we need to ask for your support, and seeing how matter-of-factly explaining our inner workings, our challenges and finances, can bring more of you in has been a real silver lining. So our online membership lead, Brian, lays it all out for you in his personal, insider account (that literally puts his skin in the game!) of how urgent things are right now.

The upshot: Being able to rally $253,000 in donations over these next few weeks is vitally important simply because it is the number that keeps us right on track, helping make sure we don't end up with a bigger gap than can be filled again, helping us avoid any significant (and knowable) cash-flow crunches for now. We used to be more nonchalant about coming up short this time of year, thinking we can make it by the time June rolls around. Not anymore.

Because the in-depth journalism on underreported beats and unique perspectives on the daily news you turn to Mother Jones for is only possible because readers fund us. Corporations and powerful people with deep pockets will never sustain the type of journalism we exist to do. The only investors who won’t let independent, investigative journalism down are the people who actually care about its future—you.

And we need readers to show up for us big time—again.

Getting just 10 percent of the people who care enough about our work to be reading this blurb to part with a few bucks would be utterly transformative for us, and that's very much what we need to keep charging hard in this financially uncertain, high-stakes year.

If you can right now, please support the journalism you get from Mother Jones with a donation at whatever amount works for you. And please do it now, before you move on to whatever you're about to do next and think maybe you'll get to it later, because every gift matters and we really need to see a strong response if we're going to raise the $253,000 we need in less than three weeks.

payment methods

WE'LL BE BLUNT

It is astonishingly hard keeping a newsroom afloat these days, and we need to raise $253,000 in online donations quickly, by October 7.

The short of it: Last year, we had to cut $1 million from our budget so we could have any chance of breaking even by the time our fiscal year ended in June. And despite a huge rally from so many of you leading up to the deadline, we still came up a bit short on the whole. We can’t let that happen again. We have no wiggle room to begin with, and now we have a hole to dig out of.

Readers also told us to just give it to you straight when we need to ask for your support, and seeing how matter-of-factly explaining our inner workings, our challenges and finances, can bring more of you in has been a real silver lining. So our online membership lead, Brian, lays it all out for you in his personal, insider account (that literally puts his skin in the game!) of how urgent things are right now.

The upshot: Being able to rally $253,000 in donations over these next few weeks is vitally important simply because it is the number that keeps us right on track, helping make sure we don't end up with a bigger gap than can be filled again, helping us avoid any significant (and knowable) cash-flow crunches for now. We used to be more nonchalant about coming up short this time of year, thinking we can make it by the time June rolls around. Not anymore.

Because the in-depth journalism on underreported beats and unique perspectives on the daily news you turn to Mother Jones for is only possible because readers fund us. Corporations and powerful people with deep pockets will never sustain the type of journalism we exist to do. The only investors who won’t let independent, investigative journalism down are the people who actually care about its future—you.

And we need readers to show up for us big time—again.

Getting just 10 percent of the people who care enough about our work to be reading this blurb to part with a few bucks would be utterly transformative for us, and that's very much what we need to keep charging hard in this financially uncertain, high-stakes year.

If you can right now, please support the journalism you get from Mother Jones with a donation at whatever amount works for you. And please do it now, before you move on to whatever you're about to do next and think maybe you'll get to it later, because every gift matters and we really need to see a strong response if we're going to raise the $253,000 we need in less than three weeks.

payment methods

We Recommend

Latest

Sign up for our free newsletter

Subscribe to the Mother Jones Daily to have our top stories delivered directly to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate